Tuberculosis

Pai, Madhukar, Behr, Marcel A., Dowdy, David, Dheda, Keertan, Divangahi, Maziar, Boehme, Catharina C., Ginsberg, Ann, Swaminathan, Soumya +4 more·2016·Nature Reviews Disease Primers

Cited by (1,000)

Items 401–500 of 1,000

  1. A microfluidic-based analysis of 3D macrophage migration after stimulation by Mycobacterium, Salmonella and Escherichia
    Sandra Pérez-Rodríguez, Carlos Borau, José Manuel García‐Aznar, Jesús Gonzalo‐Asensio · 2022 · BMC Microbiology
  2. Alginate‐Based Nanosystems for Therapeutic Applications
    Jaya Lakkakula, Arpita Roy, Karan Krishnamoorthy, Saad Ali Alghamdi, Mazen Mohammed Almehmadi, Pratik Gujarathi, Prachi Pansare, Mamdouh A. Allahyani, Osama Abdulaziz, Kamini Velhal et al. · 2022 · Journal of Nanomaterials
  3. Identification of anti-Mycobacterium tuberculosis agents targeting the interaction of bacterial division proteins FtsZ and SepFe
    Hongjuan Zhang, Ying Chen, Yu Zhang, Luyao Qiao, Xiangyin Chi, Yanxing Han, Yuan Lin, Shuyi Si, Jian‐Dong Jiang · 2023 · Acta Pharmaceutica Sinica B
  4. Identification of host regulators of Mycobacterium tuberculosis phenotypes uncovers a role for the MMGT1-GPR156 lipid droplet axis in persistence
    Haroon Kalam, Chih‐Hung Chou, Motohiko Kadoki, Daniel B. Graham, Jacques Deguine, Deborah Tan Hung, Ramnik J. Xavier · 2023 · Cell Host & Microbe
  5. Imaging of musculoskeletal tuberculosis
    Nuttaya Pattamapaspong, Thanat Kanthawang, Mouna Chelli Bouaziz, Mohamed Fethi Ladeb, Nadia Hammami, Wcg Peh · 2023 · British Journal of Radiology
  6. Construction of novel multi-epitope-based diagnostic biomarker HP16118P and its application in the differential diagnosis of Mycobacterium tuberculosis latent infection
    Jie Wang, Fan Jiang, Peng Cheng, Zhaoyang Ye, Linsheng Li, Ling Yang, Zhuang Li, Wenping Gong · 2024 · Molecular Biomedicine
  7. MR1-restricted T cell clonotypes are associated with “resistance” to Mycobacterium tuberculosis infection
    Deborah L. Cross, Erik D. Layton, Krystle K. Q. Yu, Malisa T. Smith, Melissa S. Aguilar, Shamin Li, Elise C. Wilcox, Aude G. Chapuis, Harriet Mayanja‐Kizza, Catherine M. Stein et al. · 2024 · JCI Insight
  8. Synthesis of 2-methoxy-3-(thiophen-2-ylmethyl)quinoline containing amino carbinols as antitubercular agents
    Bidhu Bhusan Karkara, Shashank Shekher Mishra, Bhupendra Narain Singh, Gautam Panda · 2020 · Bioorganic Chemistry
  9. Evaluation of a serum-based antigen test for tuberculosis in HIV-exposed infants: a diagnostic accuracy study
    Liyan Mao, Sylvia M. LaCourse, Soyeon Kim, Chang Liu, Bo Ning, Duran Bao, Jia Fan, Christopher J. Lyon, Ziyong Sun, Sharon Nachman et al. · 2021 · BMC Medicine
  10. Transcriptional Profiling of Human Peripheral Blood Mononuclear Cells Stimulated by Mycobacterium tuberculosis PPE57 Identifies Characteristic Genes Associated With Type I Interferon Signaling
    Fanli Yi, Jing Hu, Xiaoyan Zhu, Yue Wang, Qiuju Yu, Jing Deng, Xuedong Huang, Ying Ma, Yi Xie · 2021 · Frontiers in Cellular and Infection Microbiology
  11. Economic evaluation of patient costs associated with tuberculosis diagnosis and care in Solomon Islands
    Kerri A. Viney, Noel Itogo, Takuya Yamanaka, Ridha Jebeniani, Anupama Hazarika, Fukushi Morishita, Nobuyuki Nishikiori, Susana Vaz Nery · 2021 · BMC Public Health
  12. Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery
    Timothy J. de Wet, Digby Francis Warner, Valerie Mizrahi · 2019 · Accounts of Chemical Research
  13. Efficiency of screening for tuberculosis infection in children and adolescents in Moscow in 2019 based on the new procedure for using the intradermal test with tuberculosis recombinant allergen (ESAT-6/CFP-10)
    L. V. Slogotskaya, Elena M. Bogorodskaya, L. F. Shamuratova, T. A. Sevostyanova · 2021 · Tuberculosis and lung diseases
  14. The power of resistance: mechanisms of antimicrobial resistance in Mycobacterium tuberculosis and its impact on tuberculosis management
    R. Gopalaswamy, S. Subbian · 2026 · Clinical Microbiology Reviews
  15. Schistosoma mansoni Infection Is Associated With a Higher Probability of Tuberculosis Disease in HIV-Infected Adults in Kenya
    Taryn A. McLaughlin, Azhar Nizam, Felix Hayara Odhiambo, Gregory Sadat Ouma, Angela Campbell, Jeremiah Khayumbi, Joshua Ongalo, Samuel Gurrion Ouma, N. Sarita Shah, John D. Altman et al. · 2020 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  16. IL-1RA in the supernatant of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus is useful for discriminating active tuberculosis from latent infection
    Shunsuke Akashi, Maho Suzukawa, Keita Takeda, Isao Asari, Masahiro Kawashima, Nobuharu Ohshima, Eri Inoue, Ryota Sato, Masahiro Shimada, Junko Suzuki et al. · 2020 · Journal of Infection and Chemotherapy
  17. Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin
    Samantha Pillay, Geraint Davies, Marty Chaplin, Margaretha de Vos, Samuel G. Schumacher, Robin M. Warren, Karen R Steingart, Grant Theron · 2021 · Cochrane Database of Systematic Reviews
  18. Microarray-based selection of a serum biomarker panel that can discriminate between latent and active pulmonary TB
    Zhihui Li, Jianjun Hu, Peng-Chong Liu, Dan Cui, Hongqin Di, Shucai Wu · 2021 · Scientific Reports
  19. Study of CD27, CD38, HLA-DR and Ki-67 immune profiles for the characterization of active tuberculosis, latent infection and end of treatment
    Sergio Díaz-Fernández, Raquel Villar-Hernández, Zoran Stojanović, Marco A. Fernández, María Luiza de Souza-Galvão, Guillermo Tolosa, Adrián Sánchez‐Montalvá, Jorge Abad, María Ángeles Jiménez-Fuentes, Guillem Safont et al. · 2022 · Frontiers in Microbiology
  20. Impact of diabetes mellitus on immunity to latent tuberculosis infection
    Nathella Pavan Kumar, Subash Babu · 2023 · Frontiers in Clinical Diabetes and Healthcare
  21. A Spatio-temporal Bayesian model to estimate risk and influencing factors related to tuberculosis in Chongqing, China, 2014–2020
    Zhiyi Chen, Xin-Yi Deng, Yang Zou, Ying He, Sai‐Juan Chen, Qiuting Wang, Dianguo Xing, Yan Zhang · 2023 · Archives of Public Health
  22. Tuberculosis Vaccines and T Cell Immune Memory
    Fei Li, Wenrui Dang, Yunjie Du, Xiaonan Xu, Pu He, Yuhe Zhou, Bingdong Zhu · 2024 · Vaccines
  23. Promising Cytokine Adjuvants for Enhancing Tuberculosis Vaccine Immunity
    Xuezhi Cao, Yang‐Xin Fu, Hua Peng · 2024 · Vaccines
  24. Human Alveolar and Monocyte-Derived Human Macrophage Responses to Mycobacterium tuberculosis
    Monica Campo, Kimberly A. Dill‐McFarland, Glenna J. Peterson, Basilin Benson, Shawn J. Skerrett, Thomas R. Hawn · 2024 · The Journal of Immunology
  25. Identification of potent indolizine derivatives against Mycobacterial tuberculosis: In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies
    Katharigatta Narayanaswamy Venugopala, Sandeep Chandrashekharappa, Pran Kishore Deb, Nizar A. Al‐Shar’i, Melendhran Pillay, Priya Tiwari, Deepak Chopra, Pobitra Borah, Rasoul Tamhaev, Lionel Mourey et al. · 2024 · International Journal of Biological Macromolecules
  26. 2-Aryl-Benzoimidazoles as Type II NADH Dehydrogenase Inhibitors of Mycobacterium tuberculosis
    Pallavi Saha, Shashikanta Sau, Nitin Pal Kalia, Deepak Kumar Sharma · 2024 · ACS Infectious Diseases
  27. Magnitude of Mycobacterium tuberculosis Infection and Its Resistance to Rifampicin Using Xpert-MTB/RIF Assay Among Presumptive Tuberculosis Patients at Motta General Hospital, Northwest Ethiopia
    Tesfaye Andualem, Dereje K. Belayneh · 2021 · Infection and Drug Resistance
  28. Effects of Glutathione Diminishment on the Immune Responses against Mycobacterium tuberculosis Infection
    Ruoqiong Cao, Afsal Kolloli, Ranjeet Kumar, James Owens, Kayvan Sasaninia, Charles Vaughn, Mohkam Singh, Edward Truong, Nala Kachour, Abrianna Beever et al. · 2021 · Applied Sciences
  29. The circuits of healthcare: Understanding healthcare seeking behaviour—A qualitative study with tuberculosis patients in Lisbon, Portugal
    Rafaela Ribeiro, Philip J. Havik, Isabel Maria Rodrigues Craveiro · 2021 · PLoS ONE
  30. Inhibiting Adenosine Receptor Signaling Promotes Accumulation of Effector CD4+ T Cells in the Lung Parenchyma During Severe Tuberculosis
    Eduardo P. Amaral, Érika Machado de Salles, Caio César Barbosa Bomfim, Rafael Moysés Salgado, Fabrício Moreira Almeida, Paula Carolina de Souza, José María Álvarez, Mário Hiroyuki Hirata, Elena Lasunskaia, Maria Regina D’Império Lima · 2018 · The Journal of Infectious Diseases
  31. Polymorphisms in interferon pathway genes and risk of Mycobacterium tuberculosis infection in contacts of tuberculosis cases in Brazil
    Juan Manuel Cubillos-Angulo, María B. Arriaga, Mayla Gabryele Miranda de Melo, Elisângela Silva, Lucia Elena Alvarado-Arnez, Alexandre S. de Almeida, Milton Ozório Moraes, Adriana S. R. Moreira, José Roberto Lapa e Silva, Kiyoshi F. Fukutani et al. · 2019 · International Journal of Infectious Diseases
  32. Insights into the molecular pathogenesis of ocular tuberculosis
    Rupesh V. Agrawal, Ilaria Testi, Andrés Rousselot, Elizabeth J. Chen, Rajamani Lakshminarayanan, Amit Singhal, Manish Mahadeorao Bundele, Paul Edward Hutchinson, Onn Min Kon, Vishali Gupta et al. · 2020 · Tuberculosis
  33. Skin tests for the detection of Mycobacterial infections: achievements, current perspectives, and implications for other diseases
    Duthie, Malcolm S., Reed, Steven G. · 2021 · Applied Microbiology and Biotechnology
  34. Mechanisms of immune evasion by Mycobacterium tuberculosis : the impact of T7SS and cell wall lipids on host defenses
    Asrar Ahmad Malik, Mohd Shariq, Javaid Ahmad Sheikh, Udyeshita Jaiswal, Haleema Fayaz, Gauri Shrivastava, Nasreen Z. Ehtesham, Seyed E. Hasnain · 2024 · Critical Reviews in Biochemistry and Molecular Biology
  35. Whole blood GBP5 protein levels in patients with and without active tuberculosis
    Xiangyang Yao, Wei Liu, Xiaofei Li, Chen-Xi Deng, Tingdong Li, Zhouyue Zhong, Shuping Chen, Zhitan Ge, Xuejie Zhang, Shiyin Zhang et al. · 2022 · BMC Infectious Diseases
  36. Risk of cancer, tuberculosis and serious infections in patients with ankylosing spondylitis, psoriatic arthritis and psoriasis treated with IL-17 and TNF-α inhibitors: a nationwide nested case-control analysis
    Hyung Woo Kim, Eun Hwa Kim, Myeongjee Lee, Inkyung Jung, Sung Soo Ahn · 2022 · Clinical and Experimental Rheumatology
  37. A predictive model for early clinical diagnosis of spinal tuberculosis based on conventional laboratory indices: A multicenter real-world study
    Xiaojiang Hu, Guang K. Zhang, Hongqi Zhang, Mingxing Tang, Shaohua Liu, Bo Tang, Dongcheng Xu, Chengran Zhang, Qile Gao · 2023 · Frontiers in Cellular and Infection Microbiology
  38. Metformin has immunomodulatory effects which support its potential use as adjunctive therapy in tuberculosis
    Alex Sutter, Dylan M. Landis, KENNETH M. NUGENT · 2023 · Indian Journal of Tuberculosis
  39. Incidence and risk factors of tuberculosis in systemic lupus erythematosus patients: a multi-center prospective cohort study
    Lifan Zhang, Xiaoqing Zou, Nan Jiang, Lantian Xie, Jianghao Liu, Zhengrong Yang, Qifei Cao, Chunlei Li, Xiaochuan Sun, Fengchun Zhang et al. · 2023 · Frontiers in Immunology
  40. The Endogenous Retinoic Acid Receptor Pathway Is Exploited by Mycobacterium tuberculosis during Infection, Both In Vitro and In Vivo
    Yonne Karoline Tenório de Menezes, Carolina Eto, Joseana de Oliveira, Erica C. Larson, Daniel A. G. B. Mendes, Greicy Brisa Malaquias Dias, Murilo Delgobo, Abigail K. Gubernat, Janelle L. Gleim, Eduarda Laís Munari et al. · 2023 · The Journal of Immunology
  41. Advances of Long Non-Coding RNAs as Potential Biomarkers for Tuberculosis: New Hope for Diagnosis?
    Jiaojiao Xia, Yilin Liu, Yuhe Ma, Fen Yang, Yongdui Ruan, Jun‐Fa Xu, Jiang Pi · 2023 · Pharmaceutics
  42. The germ theory revisited: A noncentric view on infection outcome
    Fredric Carlsson, Lars Råberg · 2024 · Proceedings of the National Academy of Sciences
  43. Role of Type I Interferons during Mycobacterium tuberculosis and HIV Infections
    Elsa Anes, José Miguel Azevedo‐Pereira, David Pires · 2024 · Biomolecules
  44. Host long noncoding RNAs in bacterial infections
    Yong Cheng, Yurong Liang, Xuejuan Tan, Lin Liu · 2024 · Frontiers in Immunology
  45. The significance role of regulatory T cells in the persistence of infections by intracellular bacteria.
    Parisa Sabbagh, A. Karkhah, H. Nouri, M. Javanian, S. Ebrahimpour · 2018 · Infection, Genetics and Evolution
  46. Rewired Downregulation of DNA Gyrase Impacts Cell Division, Expression of Topology Modulators, and Transcription in Mycobacterium smegmatis
    Sarmistha Guha, Shubha Udupa, Wareed Ahmed, Valakunja Nagaraja · 2018 · Journal of Molecular Biology
  47. Asthma and atopy prevalence are not reduced among former tuberculosis patients compared with controls in Lima, Peru
    Anthony Byrne, Ben J. Marais, Carole Diane Mitnick, Frances L. Garden, Leonid W. Lecca, Carmen C. Contreras, Yaninna Yauri, Fanny García, Guy Barrington Marks · 2019 · BMC Pulmonary Medicine
  48. Active tuberculosis in inflammatory bowel disease patients under treatment from an endemic area in Latin America
    Flora Maria Lorenzo Fortes, Ney Boa Sorte, VICTOR MARIANO, Laíla Damasceno Andrade, Fernanda Almeida da Silva de Sá Oliveira, Monique C. A. Santos, Cláudia Ivanilda N dos Santos, Catharina A Passos, Mila Palma Pacheco, Valdiana Cristina Surlo et al. · 2020 · World Journal of Gastroenterology
  49. Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in Mycobacterium tuberculosis?
    Bruno Lopes Abbadi, Valnês S. Rodrigues-Junior, Adílio da Silva Dadda, Kenia Pissinate, Anne Drumond Villela, Maria M. Campos, Luiz Gonzaga de França Lopes, Cristiano Valim Bizarro, Pablo Machado, Eduardo Henrique Silva Sousa et al. · 2018 · Frontiers in Microbiology
  50. Regional risk of tuberculosis and viral hepatitis with tumor necrosis factor-alpha inhibitor treatment: A systematic review
    Nina Jahnich, Peter D. Arkwright · 2023 · Frontiers in Pharmacology
  51. The Role of Ultrasound in the Diagnosis of Pulmonary Infection Caused by Intracellular, Fungal Pathogens and Mycobacteria: A Systematic Review
    Mariaclaudia Meli, Lucia Spicuzza, Mattia Comella, Milena La Spina, Gian Luca Trobia, Giuseppe Fabio Parisi, Andrea Di Cataldo, Giovanna M. Russo · 2023 · Diagnostics
  52. Vaccination with mycobacterial lipid loaded nanoparticle leads to lipid antigen persistence and memory differentiation of antigen-specific T cells
    Eva Morgun, Jennifer Y. Zhu, Sultan Almunif, Sharan Kumar Reddy Bobbala, Melissa S. Aguilar, Junzhong Wang, Kathleen Conner, Yongyong Cui, Liang Cao, Chetan Seshadri et al. · 2023 · eLife
  53. Optimizing antigen selection for the development of tuberculosis vaccines
    Yang Yang, Yi-Zhen Chen, T. Xia · 2024 · Cell Insight
  54. Design of Experiment (DoE) Approach for Developing Inhalable PLGA Microparticles Loaded with Clofazimine for Tuberculosis Treatment
    Druva Sarika Rongala, Suyash M. Patil, Nitesh K. Kunda · 2024 · Pharmaceuticals
  55. B cells in perivascular and peribronchiolar granuloma-associated lymphoid tissue and B-cell signatures identify asymptomatic Mycobacterium tuberculosis lung infection in Diversity Outbred mice
    Deniz Koyuncu, Thomas Erol Tavolara, Daniel M. Gatti, Adam C. Gower, Melanie L. Ginese, Igor Kramnik, Bülent Yener, Usama Sajjad, Muhammad Khalid Khan Niazi, Metin N. Gürcan et al. · 2024 · Infection and Immunity
  56. Optimizing the cascade of prevention to protect people from tuberculosis: A potential game changer for reducing global tuberculosis incidence
    Alberto Matteelli, Gavin Churchyard, Daniela María Cirillo, Saskia den Boon, Dennis Falzon, Yohhei Hamada, Rein M G J Houben, Avinash Kanchar, Afrânio Lineu Kritski, Blessina Kumar et al. · 2024 · PLOS Global Public Health
  57. Oxidative battles in tuberculosis: walking the ferroptotic tightrope
    Mariana Araújo‐Pereira, Bruno B. Andrade · 2025 · Trends in Immunology
  58. AbmR (Rv1265) is a novel transcription factor of Mycobacterium tuberculosis that regulates host cell association and expression of the non‐coding small RNA Mcr11
    Roxie C. Girardin, Guangchun Bai, Jie He, Haixin Sui, Kathleen A. McDonough · 2018 · Molecular Microbiology
  59. Heterogeneous infectiousness in mathematical models of tuberculosis: A systematic review
    Yayehirad Alemu Melsew, Adeshina Israel Adekunle, Allen C. Cheng, Emma Sue McBryde, Romain R. Ragonnet, James McCracken Trauer · 2019 · Epidemics
  60. Aging increases the systemic molecular degree of inflammatory perturbation in patients with tuberculosis
    Deivide Oliveira-de-Souza, Caian L. Vinhaes, María B. Arriaga, Nathella Pavan Kumar, Artur T. L. Queiroz, Kiyoshi F. Fukutani, Subash Babu, Bruno B. Andrade · 2020 · Scientific Reports
  61. Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV
    Katharina Kusejko, Huldrych F. Günthard, Gregory S. Olson, Kyra D. Zens, Katharine Darling, Nina Khanna, Hansjakob Furrer, Pauline Vetter, Enos Bernasconi, Pietro Vernazza et al. · 2020 · PLoS Biology
  62. Mycobacterial heparin-binding hemagglutinin (HBHA)-induced interferon-γ release assay (IGRA) for discrimination of latent and active tuberculosis: A systematic review and meta-analysis
    Jinhua Tang, Yuan Chun Huang, Zheng Cai, Yueyun Ma · 2021 · PLoS ONE
  63. Development and validation of simple and sensitive HPLC-UV method for ethambutol hydrochloride detection following transdermal application
    Qonita Kurnia Anjani, Akmal Hidayat Bin Sabri, Ryan F. Donnelly · 2021 · Analytical Methods
  64. Long Non-coding RNAs in Tuberculosis: From Immunity to Biomarkers
    Xianyi Zhang, Chan Chen, Yuzhong Xu · 2022 · Frontiers in Microbiology
  65. Review—Electrochemical Aptasensor for Pathogenic Bacteria Detection
    Thi-Thuy Duong Pham, Le Minh Tu Phan; Phan Le Minh Tu, Juhyun Park, Sungbo Cho · 2022 · Journal of The Electrochemical Society
  66. Factors contributing to pre-treatment loss to follow-up in adults with pulmonary tuberculosis: a qualitative evidence synthesis of patient and healthcare worker perspectives
    Mercy Mulaku, Bruce Nyagol, Eddy Johnson Owino, Eleanor Ochodo, Taryn Young, Karen R Steingart · 2022 · Global Health Action
  67. Mycobacterial phosphodiesterase Rv0805 is a virulence determinant and its cyclic nucleotide hydrolytic activity is required for propionate detoxification
    James R. McDowell, Guangchun Bai, Erica Lasek‐Nesselquist, Leslie E. Eisele, Yan Wu, Gregory J. Hurteau, Richard Johnson, Yinlan Bai, Yong Chen, John Chan et al. · 2023 · Molecular Microbiology
  68. Striking the right immunological balance prevents progression of tuberculosis
    Shachi Vyas, Ritobrata Goswami · 2017 · Inflammation Research
  69. Screening for infectious diseases in newly arrived migrants in Europe: the context matters
    Takis Panagiotopoulos · 2018 · Eurosurveillance
  70. Genome analyses of 174 strains of Mycobacterium tuberculosis provide insight into the evolution of drug resistance and reveal potential drug targets
    Helianthous Verma, Shekhar Nagar, Shivani Vohra, Shubhanshu Pandey, Devi Lal, Ram Krishan Negi, Rup Lal, Charu Dogra Rawat · 2021 · Microbial Genomics
  71. CD84 is a Suppressor of T and B Cell Activation during Mycobacterium tuberculosis Pathogenesis
    Nan Zheng, Joy Fleming, Peilei Hu, Jianjian Jiao, Guoqin Zhang, Ruifang Yang, Chuanyou Li, Yi Liu, Lijun Bi, Hongtai Zhang · 2022 · Microbiology Spectrum
  72. Updated considerations in the diagnosis and management of tuberculosis infection and disease: integrating the latest evidence-based strategies
    D. Graciaa, M. Schechter, K. Fetalvero, L. Cranmer, R. Kempker, K. Castro · 2023 · Expert Review of Anti-Infective Therapy
  73. Discovery, Synthesis, and Optimization of 1,2,4-Triazolyl Pyridines Targeting Mycobacterium tuberculosis
    Tomayo I. Berida, Samuel R. McKee, Shamba Chatterjee, Destinee L. Manning, Wei Li, Pankaj Pandey, Siddharth Tripathi, Yassin Mreyoud, Asya Smirnov, Robert J. Doerksen et al. · 2023 · ACS Infectious Diseases
  74. TRAF6 triggers Mycobacterium-infected host autophagy through Rab7 ubiquitination
    Qinmei Ma, Jialin Yu, Li Liu, Xiaoyan Ma, Jiaxue Zhang, Jiamei Zhang, Xiaoping Wang, Guangcun Deng, Xiaoling Wu · 2023 · Cell Death Discovery
  75. Camel urine as a potential source of bioactive molecules showing their efficacy against pathogens: A systematic review
    Ressmi Amina, R. Habiba, B. Abouddihaj · 2024 · Saudi Journal of Biological Sciences
  76. Mycobacterial SapM hampers host autophagy initiation for intracellular bacillary survival via dephosphorylating Raptor
    Wei Zhang, Chunsheng Dong, Sidong Xiong · 2024 · iScience
  77. Potential of Mycobacterium tuberculosis Type II NADH-Dehydrogenase in Antitubercular Drug Discovery
    Pallavi Saha, Mahesh Kumar, Deepak Kumar Sharma · 2025 · ACS Infectious Diseases
  78. How Can Elispot Add Information to Improve Knowledge on Tropical Diseases?
    Josué da Costa Lima‐Junior, Fernanda Nazaré Morgado, Fátima Conceição‐Silva · 2017 · Cells
  79. Evaluation of a synthetic peptide for the detection of anti-Mycobacterium tuberculosis curli pili IgG antibodies in patients with pulmonary tuberculosis
    Natasha Naidoo, Balakrishna Pillay, Martin Bubb, Alexander S. Pym, Thamsanqa E. Chiliza, Kogieleum Naidoo, Thumbi Ndung’u, Victoria O Kasprowicz, Manormoney Pillay · 2018 · Tuberculosis
  80. Are tolerance and training required to end TB?
    Maziar Divangahi · 2018 · Nature reviews. Immunology
  81. Impact of individual-level factors on Ex vivo mycobacterial growth inhibition: Associations of immune cell phenotype, cytomegalovirus-specific response and sex with immunity following BCG vaccination in humans
    Satria A. Prabowo, Steven G. Smith, Karin Seifert, Helen A. Fletcher · 2019 · Tuberculosis
  82. MymA Bioactivated Thioalkylbenzoxazole Prodrug Family Active against Mycobacterium tuberculosis
    Abraham L. Moure, Gagandeep S. Narula, Flavia Sorrentino, Adama L. Bojang, Clement K. M. Tsui, Carine Sao Emani, Esther Porras de Francisco, Beatriz Díaz, María José Rebollo-López, Pedro Alfonso Torres-Gómez et al. · 2020 · Journal of Medicinal Chemistry
  83. The single recombinant M. tuberculosis protein DPPD provides enhanced performance of skin testing among HIV-infected tuberculosis patients
    Roberto José da Silva Badaró, Bruna Aparecida Souza Machado, Malcolm S. Duthie, César A. Araújo‐Neto, D Pedral-Sampaio, Maria Nakatani, Steven G. Reed · 2020 · AMB Express
  84. Epidemiological profile of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis among Congolese patients
    Darrel Ornelle Elion Assiana, Jabar Babatunde Pacome Agbo Achimi Abdul, Laure Stella Ghoma Linguissi, Micheska Epola Dibamba Ndanga, Jeannhey Christevy Vouvoungui, Albert Mabiala, Christopher Mebiame Biyogho, Jean Ronald Edoa, Bayodé Roméo Adégbitè, Ayôla Akim Adégnika et al. · 2021 · Annals of Clinical Microbiology and Antimicrobials
  85. Declining incidence rate of tuberculosis among close contacts in five years post-exposure: a systematic review and meta-analysis
    Ying Du, Yijun He, Haoran Zhang, Fei Shen, Ling Guan, Henan Xin, Yongpeng He, Xuefang Cao, Boxuan Feng, Zhusheng Quan et al. · 2023 · BMC Infectious Diseases
  86. Biomarkers for Treatment Monitoring in Tuberculosis: A New Hope
    Subash Babu · 2017 · EBioMedicine
  87. Far-UVC light applications: sterilization of MRSA on a surface and inactivation of aerosolized influenza virus
    DAVID F. WELCH, Henry M. Spotnitz, David J. Brenner, Gerhard Randers-Pehrson, Manuela Buonanno, Igor Shuryak · 2018 · Photonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases
  88. Investigating the impact of TB case-detection strategies and the consequences of false positive diagnosis through mathematical modelling
    Marek Lalli, Matthew Hamilton, Carel Pretorius, Debora Pedrazzoli, Richard Guy White, Rein M G J Houben · 2018 · BMC Infectious Diseases
  89. An extensive review of studies on mycobacterium cell wall polysaccharide-related oligosaccharides – part I: Synthetic studies on arabinofuranosyl oligosaccharides
    Lizhen Wang, Zhongwu Guo · 2019 · Journal of Carbohydrate Chemistry
  90. Crystal structures of the closed form ofMycobacterium tuberculosisdihydrofolate reductase in complex with dihydrofolate and antifolates
    João Augusto Ribeiro, S.M. Chavez-Pacheco, Gabriel Stephani de Oliveira, C.S. Silva, João Henrique Pimenta Giudice, Gerardo Andrés Libreros-Zúñiga, M.V.B. Dias · 2019 · Acta Crystallographica Section D Structural Biology
  91. Oak‐Associated Negativicute Equipped with Ancestral Aromatic Polyketide Synthase Produces Antimycobacterial Dendrubins
    Keishi Ishida, Gulimila Shabuer, Sebastian Schieferdecker, Sacha J. Pidot, Timothy Paul Stinear, Uwe Knüpfer, Michael Cyrulies, Christian Hertweck · 2020 · Chemistry - A European Journal
  92. Organic Salts Based on Isoniazid Drug: Synthesis, Bioavailability and Cytotoxicity Studies
    Filipa Santos, Luís Cobra Branco, Ana Rita C. Duarte · 2020 · Pharmaceutics
  93. Role of circular RNAs in visceral organ fibrosis
    Xiaoniu Dai, Yusi Cheng, Cuifen Wang, Jie Huang, Jie Chao · 2021 · Food and Chemical Toxicology
  94. Radiological difference between new sputum-positive and sputum-negative pulmonary tuberculosis
    Deependra K. Rai, Ravi Kirti, Subhash Kumar, Saurabh Karmakar, Somesh Thakur · 2019 · Journal of Family Medicine and Primary Care
  95. Rv2231c, a unique histidinol phosphate aminotransferase from Mycobacterium tuberculosis, supports virulence by inhibiting host-directed defense
    Zarin, Sheeba, Shariq, Mohd., Rastogi, Nilisha, Ahuja, Yashika, Manjunath, P., Alam, Anwar, Hasnain, Seyed Ehtesham, Ehtesham, Nasreen Zafar · 2024 · Cellular and Molecular Life Sciences
  96. Application of antimicrobial drugs in Mycobacterium tuberculosis and research progress
    Ying Wang, Daxing Cao, Guihua Liu · 2025 · Microbial Pathogenesis
  97. The roles of long noncoding RNA-mediated macrophage polarization in respiratory diseases
    Xin Qiao, Yuxiao Ding, Dasen Wu, Anle Zhang, Yan Yin, Qiuyue Wang, Wei Ting Wang, Jian Kang · 2023 · Frontiers in Immunology
  98. Host Blood Transcriptional Signatures as Candidate Biomarkers for Predicting Progression to Active Tuberculosis
    Chang Ho Kim, Gahye Choi, Jaehee Lee · 2023 · Tuberculosis & respiratory diseases
  99. SIRT2 inhibition by AGK2 enhances mycobacteria-specific stem cell memory responses by modulating beta-catenin and glycolysis
    Ashima Bhaskar, Isha Pahuja, Kriti Negi, Akanksha Verma, Antara Ghoshal, Babu Mathew, Gaurav Tripathi, Jaswinder Singh Maras, Shivam Chaturvedi, Ved Prakash Dwivedi · 2023 · iScience
  100. Systematic review of innate immune responses against Mycobacterium tuberculosis complex infection in animal models
    Luisa María Nieto Ramírez, Carolina Mehaffy, Karen M. Dobos · 2025 · Frontiers in Immunology